Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-18

Clinical Trial Update: Radioimmunoimaging of Light Chain (AL) Amyloidosis [Phase 1]

View source ↗

Summary

The update reports completion of a Phase 1 trial evaluating a radioimmunoimaging approach for AL amyloidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Tennessee | Conditions: AL Amyloidosis | Phase 1 | Status: COMPLETED